Paul S. Mischel lab

Our laboratory aims to transform the care of patients with glioblastoma, the most common form of adult brain cancer, through molecular medicine. We use a combination of genetic and functional approaches to better understand the signaling and biochemical networks that are altered in glioblastoma with the goal of developing more effective, less toxic treatments.